Literature DB >> 4038436

Vascular tumors produced by NIH/3T3 cells transfected with human AIDS Kaposi's sarcoma DNA.

S C Lo, L A Liotta.   

Abstract

Patients with the acquired immunodeficiency syndrome (AIDS) have a high incidence of Kaposi's sarcoma. The etiology, histogenesis, and neoplastic nature of this neoplasm have been controversial. We have therefore searched for transforming gene(s) associated with AIDS Kaposi's sarcoma. DNA from an AIDS patient's Kaposi's sarcoma was transfected into NIH 3T3 cells. Control DNA was derived from human fibroblasts or salmon sperm. Kaposi's sarcoma DNA, but not the control DNA, transforms NIH/3T3 cells with a frequency of approximately 0.02 foci per 5 X 10(5) cells/micrograms DNA. The primary and secondary transfectants contain human repetitive DNA sequences. The transfected clones produced hemorrhagic angiosarcomatous neoplasms when implanted in nude mice. The histology of the nude mouse tumors is very similar to human Kaposi's sarcoma. The tumor produced by some transfectants is highly invasive and metastatic in nude mice. No significant homologues of rasN, rasH, rasK, v-sis, v-src and v-fes oncogenes (known to transform NIH/3T3 cells) were identified in the Kaposi's sarcoma DNA-transformed cells. Thus, AIDS Kaposi's sarcoma DNA may contain a distinct transforming gene(s).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038436      PMCID: PMC1887845     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Transformation of NIH/3T3 mouse cells by DNA of Rous sarcoma virus.

Authors:  N G Copeland; A D Zelenetz; G M Cooper
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

2.  Transfection by exogenous and endogenous murine retrovirus DNAs.

Authors:  N G Copeland; G M Cooper
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

3.  Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells.

Authors:  H Green; O Kehinde
Journal:  Cell       Date:  1976-01       Impact factor: 41.582

4.  Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.

Authors:  S A Aaronson; G J Todaro
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Three different human tumor cell lines contain different oncogenes.

Authors:  M J Murray; B Z Shilo; C Shih; D Cowing; H W Hsu; R A Weinberg
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

7.  Partial nucleotide sequence of the 300-nucleotide interspersed repeated human DNA sequences.

Authors:  C M Rubin; C M Houck; P L Deininger; T Friedmann; C W Schmid
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

8.  Disseminated Kaposi's sarcoma syndrome in young homosexual men.

Authors:  A E Friedman-Kien
Journal:  J Am Acad Dermatol       Date:  1981-10       Impact factor: 11.527

9.  Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads.

Authors:  C W Boone
Journal:  Science       Date:  1975-04-04       Impact factor: 47.728

10.  Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.

Authors:  G J TODARO; H GREEN
Journal:  J Cell Biol       Date:  1963-05       Impact factor: 10.539

View more
  3 in total

1.  HIV-associated Kaposi's sarcoma: new developments in epidemiology and molecular pathology.

Authors:  W K Roth
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Lymphaticovenous differentiation in Kaposi's sarcoma. Cellular phenotypes by stage.

Authors:  M Dictor; C Andersson
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

Review 3.  Endothelial heterogeneity and the acquired immunodeficiency syndrome: a paradigm for the pathogenesis of vascular disorders.

Authors:  S Goerdt; C Sorg
Journal:  Clin Investig       Date:  1992-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.